Bilayer Therapeutics, Inc.

Bilayer is developing first-in-class therapeutics for constipation and other diseases of the colon such as diabetes, obesity, metabolic disorders

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Founded June 2020
  • Employees 1
  • Incorporation Type C-corp
  • Website bilayer-therapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free